Medications

FDA panel backs removal of unproven pregnancy drug

Federal health advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.

Obstetrics & gynaecology

Experts say access to late terminations in Queensland is vital

Despite advances in imaging and prenatal screening, not all abnormalities are detectable early in pregnancy, making safe late termination services essential for equitable reproductive health care, according to the authors ...

page 5 from 18